AE
AXON ENTERPRISE, INC. (AXON)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 delivered record revenue of $0.669B (+33% y/y, +11% q/q) with broad-based strength and raised FY25 revenue and Adjusted EBITDA guidance; Non-GAAP EPS was $2.12 and Adjusted EBITDA was $0.172B with a 25.7% margin .
- Results beat Street: revenue by ~$27.6M (~4.3%) and Non-GAAP EPS by ~$0.66; Adjusted EBITDA beat consensus by ~$10.4M* (S&P Global) .
- Software & Services grew 39% to $292M with net revenue retention rising to 124%; Connected Devices grew 29% to $376M; TASER +19%, Personal Sensors +24%, Platform Solutions +86% .
- Guidance raised: FY25 revenue to $2.65–$2.73B (from $2.60–$2.70B) and Adjusted EBITDA to $665–$685M (from $650–$675M), maintaining ~25% margin; tariffs shift to impact more in 2H .
What Went Well and What Went Wrong
-
What Went Well
- Strong top-line and quality of growth: revenue +33% y/y; Software & Services +39% y/y; ARR +39% to $1.183B; net revenue retention increased to 124% .
- New product momentum and bookings: $150M AI Era Plan bookings in Q2; fastest adoption across Draft One, TASER 10, Axon Body 4; largest company deal booked, with strong corrections/international contributions .
- Management confidence and raised outlook: FY25 revenue and Adjusted EBITDA guidance increased; margin discipline maintained at ~25%; tariffs timing now skewed to 2H .
- Quote: “Draft One remains our fastest adopted software solution. TASER 10, our fastest adopted TASER weapon. Axon Body 4, our fastest adopted camera.” — Rick Smith .
-
What Went Wrong
- GAAP profitability constrained by non-cash items: operating loss of $1M and heavy stock-based compensation ($139M) drove GAAP net income margin down to 5.4% (vs 14.6% in Q1) .
- Cash flow pressure: operating cash outflow of $92M; free cash outflow of $115M; adjusted free cash outflow of $111M, with net cash position down $44M q/q to ~$66M .
- Device margins compressed: Connected Devices gross margin declined to 48.6% (−270 bps y/y) and adjusted gross margin to 51.1% (−230 bps y/y) on mix (platform solutions) .
- Analyst concern: platform solutions growth may be “lumpy”; management flagged tariff cost timing to hit 2H .
Financial Results
Segment breakdown
Product categories
KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- Strategic posture: “Demand for new technology…is accelerating…Artificial intelligence, drones and robotics, real-time operations…there’s no one breakout product…It’s everything.” — Rick Smith .
- Bookings momentum: “We closed almost $150,000,000 of bookings for our AI Era Plan in Q2 alone, and over 30% of bookings this quarter came from new product categories.” — Josh Isner .
- Margin/Outlook: “Adjusted EBITDA margin of 25.7% came in ahead of expectations…benefiting from the timing of tariffs, which will now impact us more in the second half of the year.” — Brittany Bagley .
- Counter-drone positioning: “We are…a market leader…we’re seeing just a ton of demand across the spectrum for people realizing that they need solutions here.” — Rick Smith .
- FedRAMP: “We are FedRAMP compliant at the moment…waiting…the committee…officially giving that last check mark.” — Jeff Kunins .
Q&A Highlights
- AI Era Plan acceleration: $150M Q2 bookings; customer ROI measured in staffing/time savings; bundle increasingly includes AI Assistant, real-time translation; pipeline loaded for 2H .
- Platform Solutions and counter-drone: Strong demand; management cautions for lumpiness; counter-drone is one of multiple growth drivers within the segment .
- DFR and Skydio: Partnership momentum; monetization primarily software (Dedrone) and services; Skydio hardware via referral/partner agreements; autonomy reduces labor cost versus manual deployments .
- International: Multiple large deals; Europe interest in border security, TASER 10 and translation; management expects strong 2H quarters .
- Pricing and upsell: Per-officer value can reach ~$600 at the high end as agencies adopt premium bundles and AI; ~70% of customers still on basic plans—ample upsell runway .
- Tariffs: Guidance fully bakes current view; impacts shift to 2H; supply chain flexibility cited .
- TASER 10 capacity: Capacity ramp continuing into next year; demand still outpacing supply .
Estimates Context
- Q2 2025: Revenue $668.5M vs consensus $641.0M; Non-GAAP EPS $2.12 vs consensus $1.46; Adjusted EBITDA $171.6M vs consensus $161.3M* (Values retrieved from S&P Global).
- Q1 2025: Revenue $603.6M vs consensus $586.3M; Non-GAAP EPS $1.41 vs consensus $1.28* (Values retrieved from S&P Global).
- FY 2025 Street revenue stands near the high-end of raised guidance ($2.738B consensus vs $2.65–$2.73B guide); Expect estimate revisions higher on software momentum and bookings conversion, tempered by 2H tariff cost timing (Values retrieved from S&P Global).
Disclaimer: Values retrieved from S&P Global.
Key Takeaways for Investors
- Revenue, EPS, and Adjusted EBITDA beats with raised FY25 guidance create positive estimate-revision momentum; watch for continued software mix expansion to sustain margins despite device mix headwinds .
- AI adoption is a real driver: $150M Q2 AI Plan bookings and tangible time savings for officers signal durable demand, a key narrative supporting multiple expansion and bookings-to-revenue conversion in 2H/2026 .
- Platform Solutions and counter-drone are growing rapidly but can be lumpy; margin impact from mix should normalize as software ramps and capacity expands (e.g., TASER 10) .
- International and enterprise pipelines are strengthening; near-term catalysts include large European deals and gaming/enterprise video deployments (FUSUS + body cams) .
- Tariff costs shift to 2H; guidance incorporates known impacts—near-term headwind to margins but not to growth outlook; monitoring cost mitigation execution is prudent .
- Upsell runway remains significant: ~70% of customers on basic plans; premium bundle and AI adoption should support ARR growth and retention at elevated levels .
- Liquidity remains solid despite opex-heavy investment and near-term cash outflow; net cash ~$66M and ample investments support capacity and R&D roadmap .